Cellcom Israel Announces Changes to Compensation Policy and Indemnification and Exemption Letters Included on Agenda of July 27, 2020 Annual Shareholder Meeting and Postponment of Annual Sharehold…

NETANYA, Israel, July 26, 2020 /PRNewswire/ -- Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company") announced today that following the Company's notice of 2020 annual general meeting of shareholders scheduled to take place on July  27, 2020, in which the Company's shareholders will be asked to approve, inter alia, the Company's compensation policy (the compensation policy was attached as Appendix A to the proxy statement of such meeting) and granting an indemnification and exemption letter to office holders who are, or are related to, our controlling shareholders, or in respect of whom our controlling shareholders have a personal interest in receiving indemnification and exemption letters from the Company (the letter of exemption and indemnification was attached as Appendix B to the proxy statement of such meeting), the Company shall amend its compensation policy and its letter of exemption and indemnification to be issued to its office holders, as from the approval of those resolutions by the General Meeting, to include the following amendments: (1)  The exemption granted in section 1 of the Indemnification Letter shall not apply to a decision or a transaction in which the controlling shareholder or any officer of the company has a personal interest, as To keep reading about Cellcom Israel Announces Changes to Compensation Policy and Indemnification and Exemption Letters Included on Agenda of July 27, 2020 Annual Shareholder Meeting and Postponment of Annual Sharehold…, Click on the link. Seoul, Korea
http://dlvr.it/RcPrL8

Comments

Post a Comment

Popular posts from this blog

AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts

Image
(RTTNews) - AstraZeneca Plc (AZN.L, AZN) said first participants have been dosed in a Phase I trial of AZD7442 for the prevention and treatment of COVID-19. The trial will evaluate the safety, tolerability and pharmacokinetics of AZD7442. It will include up to 48 healthy participants in the UK aged 18 to 55 years. AZD7442 is a combination of two monoclonal antibodies derived from convalescent patients with SARS-CoV-2 infection. Discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020, the mAbs were optimised by AstraZeneca. Data readout from the trial is anticipated in the second half of 2020. To keep reading about AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts, Click on the link. Seoul, Korea http://dlvr.it/RfHgSK
Read more

AT&T Sells DirecTV Stake To Private Equity Firm TPG

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. (RTTNews) - AT&T Inc. (T) has reached a deal with private equity firm TPG Capital to make its struggling satellite TV provider DirecTV a new standalone company. The deal will establish a new company that will own and operate AT&T's U.S. video business unit consisting of the DirecTV, AT&T TV and U-verse video services. The new company will have an enterprise value of $16.25 billion. The company will be jointly governed by a board with two representatives from each of AT&T and TPG, as well as a fifth seat for the CEO, which at closing will be Bill Morrow, CEO of AT&T's U.S. video unit. Following the close of the transaction, AT&T will own 70% of the common equity and TPG will own 30%. AT&T will receive $7...
Read more

7 lies to stop telling yourself if you want to become mentally stronger

Image
Crystal Cox/Business Insider Amy Morin is a psychotherapist, licensed clinical social worker, mental strength coach, and international bestselling author. She explains that sometimes our own thoughts can hold us back, especially if we tend to dwell on negative events, insecurities, and self-doubt. Morin says it's important to confront thoughts like "I'm not good enough" or "I'm too damaged," and replace them with self-empathy by instead saying "I am worth it" or "I'm a survivor." Visit Business Insider's homepage for more stories. Many of the things you tell yourself aren't true. And there's a good chance you've bought into some unhealthy beliefs over the years. Courtesy of Amy Morin In the therapy world, we call these "cognitive distortions." We all have them. Learning to recognize these lies we tell ourselves and replace them with healthier, more realistic statements is key to building mental str...
Read more